Bile acids associate with specific gut microbiota, low-level alcohol consumption and liver fibrosis in patients with non-alcoholic fatty liver disease

QR Code

Bile acids associate with specific gut microbiota, low-level alcohol consumption and liver fibrosis in patients with non-alcoholic fatty liver disease

© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd Background: Bile acids (BAs) are synthesized by the liver and modified by gut bacteria, and may play an intermediary role between the gut microbiome and liver in promoting fibrosis in non-alcoholic fatty liver disease (NAFL...

Full description

Bibliographic Details
Main Authors:	Adams, L.A., Wang, Z., Liddle, C., Melton, Phillip E., Ariff, A., Chandraratna, H., Tan, J., Ching, H., Coulter, S., de Boer, B., Christophersen, Claus, O’Sullivan, T.A., Morrison, M., Jeffrey, G.P.
Format:	Journal Article
Language:	English
Published:	WILEY 2020
Subjects:	Science & Technology Life Sciences & Biomedicine Gastroenterology & Hepatology deoxycholic acid diet fibrosis microbiome non-alcoholic steatohepatitis FARNESOID X RECEPTOR STEATOHEPATITIS INFLAMMATION MODULATION MECHANISM PROFILE NASH TERM
Online Access:	http://hdl.handle.net/20.500.11937/79136

Similar Items

The effect of modified alternate day calorie restriction on non-alcoholic fatty liver disease (NAFLD)
by: Yusoff, Khairiah Mat
Published: (2018)

The effect of modified alternate day calorie restriction (MACR) on non-alcoholic fatty liver disease (NAFLD)
by: Johari, Muhammad Izzad
Published: (2017)

Omics approach to investigate musculoskeletal, liver and metabolic traits
by: Mehta, Ojasvi
Published: (2023)

Mortality rate of alcoholic liver disease and risk of hospitalisation for alcoholic liver cirrhosis, alcoholic hepatitis, and alcoholic liver failure in Australia between 1993 and 2005
by: Liang, Wenbin, et al.
Published: (2010)

Role of TWEAK in coregulating liver progenitor cell and fibrogenic responses
by: Tirnitz-Parker, Nina, et al.
Published: (2014)

Risk factors for gut dysbiosis in early life
by: Parkin, K., et al.
Published: (2021)

The role of a plant-based diet in the pathogenesis, etiology and management of the inflammatory bowel diseases
by: Grosse, C.S.J., et al.
Published: (2020)

Association between non-alcoholic fatty liver disease (NAFLD) and cardiovascular Disease (CVD) risk categories among adult patients attending UiTM Primary Care Clinics / Hayatul Najaa Miptah
by: Miptah, Hayatul Najaa
Published: (2019)

Beyond the human genome: microbes, metaphors and what it means to be human in an interconnected post-genomic world
by: Nerlich, Brigitte, et al.
Published: (2009)

MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C
by: Thabet, Khaled, et al.
Published: (2016)

Economic evaluation of a community-based diagnostic pathway to stratify adults for non-alcoholic fatty liver disease: a Markov model informed by a feasibility study
by: Tanajewski, Lukasz, et al.
Published: (2017)

Retrospective study on the management of liver trauma: a 7-year experience in a hepatobiliary center
by: Yusoff, Muhammad Za'im Mohammad
Published: (2021)

Probiotic Lactobacillus Rhamnosus GG Protects Against P. Gingivalis And F. Nucleatum Gut Dysbiosis.
by: Gatej, Simona M, et al.
Published: (2020)

Effect of heterotrigona itama bee bread on metabolic dysfunction-associated fatty liver disease parameters in obese male rats
by: Zakaria, Zaida
Published: (2022)

Current and future magnetic resonance technologies for assessing liver disease in clinical and experimental medicine
by: Bawden, Stephen, et al.
Published: (2017)

Lifestyle interventions for non-alcoholic fatty liver disease
by: Ahmed, Idris Adewale, et al.
Published: (2019)

TWEAK/Fn14 signalling promotes cholangiocarcinoma niche formation and progression
by: Dwyer, Ben, et al.
Published: (2021)

Evaluation of Entamoeba histolytica Acetyl Co-A Synthetase Recombinant Protein (rEhACS) for Serodiagnosis of Acute Amoebic Liver Abscess in Humans
by: Sith, Nur Shafiqa Md
Published: (2015)

Observation of the bile canaliculi of Puntius javanicus liver affected by copper
by: Sabullah, Mohd Khalizan, et al.
Published: (2015)

A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis
by: Friedman, Scott L., et al.
Published: (2018)

TWEAK and LTß Signaling during Chronic Liver Disease
by: Dwyer, Benjamin, et al.
Published: (2014)

Investigation into different approaches in the fight against antimicrobial resistance: studying the microbiome using human gastric organoids, bioinformatic analysis of a hospital outbreak and predatory bacteria as a therapeutic
by: Ford, Rhian Marie
Published: (2021)

Disturbed gut microbiota explains persistent abdominal pain after a major environmental disaster
by: Yusof, Nurfadhilah
Published: (2017)

The role of Wnt/β-catenin signalling in the regulation of liver progenitor cell responses in non-alcoholic fatty liver disease
by: Shirolkar, Gayatri Dhananjay
Published: (2021)

Analysis of genotyping for predicting liver injury marker, Procollagen III in persons at risk of non-alcoholic fatty liver disease
by: Grove, Jane I., et al.
Published: (2018)

The relation between retinoids and non-alcoholic fatty liver: a review
by: Buyong, Zunariah, et al.
Published: (2019)

Correlation of liver elastography with lipid profile, liver function test, and HbA1c in type II diabetes with non-alcoholic fatty liver disease in Hospital Universiti Sains Malaysia
by: Subbramaniam, Subashini A/P
Published: (2016)

SOX9 predicts progression towards cirrhosis in patients while its loss protects against liver fibrosis
by: Athwal, Varinder S., et al.
Published: (2017)

Aberrant post-translational protein modifications in the pathogenesis of alcohol-induced liver injury
by: Osna, Natalie, et al.
Published: (2016)

Opportunistic bacteria confer the ability to ferment prebiotic starch in the adult cystic fibrosis gut
by: Wang, Y., et al.
Published: (2019)

Treating alcohol-related liver disease from a public health perspective
by: Hydes, T., et al.
Published: (2019)

Effects of HFE gene mutations and alcohol on iron status, liver biochemistry and morbidity
by: Olynyk, John, et al.
Published: (2011)

Characteristics of liver transplant candidates delisted following recompensation and predictors of such delisting in alcohol-related liver disease: a case-control study
by: Aravinthan, Aloysious D., et al.
Published: (2017)

Mechanism-based intervention in Non-Alcoholic Fatty Liver Disease: mapping the muscle-liver axis and exploring the effect of L-carnitine on liver fat, insulin sensitivity and mitochondrial energy kinetics
by: Thiagarajan, Prarthana
Published: (2021)

Isolation of Vibrio cholerae in Homogenized Tissues of Liver, Gall Bladder and Bile in Rabbit Model

Cardiovascular disease, cancer and mortality among people with type 2 diabetes and alcoholic or non-alcoholic fatty liver disease hospital admission
by: Wild, Sarah H., et al.
Published: (2018)

Understanding the Relationship between Iron and Lipid Metabolism in Non-alcoholic Fatty Liver Disease
by: Singh, Abhishek Kumar
Published: (2022)

Elucidation Of The Molecular Mechanisms Of Orthosiphon Aristatus Extract In Non-Alcoholic Fatty Liver Disease
by: Al Shehade, Salah Abd Alrazak
Published: (2023)

Resistant starch is actively fermented by infant faecal microbiota and increases microbial diversity
by: Gopalsamy, G., et al.
Published: (2019)

Serum marker of inflammasome activity correlates with liver injury in nonalcoholic fatty liver disease and is influenced by genetic polymorphisms
by: Adams, L., et al.
Published: (2015)